In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
Tweet The escalating approach to MS was based on failure. Failure drug 1 go to drug 2, fail go to drug 3 and hope that its not too late to limit progression occurring. This is a problem of the softly softly approach but the we’ll…
Tweet I guesss you all know this, but here is an example of an EBV infection 16 years before MS developed. So what happens in the interviening time and why are things unnoticed. One element to this is neurological researve. So just like the pancreas…
When a writer stops writing the reasons are usually pretty expected. Your mind suddenly goes blank and all of the topics that you had in the back of your head wiggling around go away or seem irrelevant or unimportant. I talked to my therapist about…
Close relatives of people with multiple sclerosis (MS) are 100 times more likely to develop the neurological disorder than the general population, according to a new analysis of GEMS data. Among participants in GEMS, a large-scale observational study assessing MS risk among family members, about…
It’s definitely dark and maybe even disturbing, but a book I have always enjoyed is Thomas Harris’ “The Silence of the Lambs.” If you’re unfamiliar with either the book or the movie, you’ve either been living a sheltered life or you need to find someone…
The National Multiple Sclerosis Society has designated UC Davis Health in California as a new Center for Comprehensive MS Care, recognizing its ability to provide coordinated, multidisciplinary care for people with multiple sclerosis (MS). The designation is part of the society’s Network of MS Healthcare…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
Innocare Pharma has dosed the first healthy volunteer in a clinical trial in China testing ICP-538, its oral treatment candidate for multiple sclerosis (MS) and other autoimmune diseases. The novel experimental therapy works by promoting the degradation of the VAV1 protein, essential for the function…
People with multiple sclerosis (MS) who experience their first symptoms after age 50 tend to have faster disability progression than those with earlier disease onset, according to a recent study. The also more commonly develop primary progressive MS (PPMS). In addition, late-onset MS was associated with a…